Strength Seen in Heska (HSKA): Stock Jumps 5.7% in Session
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:35AM CDT
Heska Corporation (HSKA) was a big mover last session, as the company saw its shares rise around 6% on the day.
HSKA: 43.50 (-0.02), ENZ: 6.18 (+0.24)
Myriad Genetics myChoice Cancer Test Findings Encourage
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:34AM CDT
With respect to myChoice HRD test, Myriad earlier noted that it expects to serve a worldwide market size of $18.5 billion (compared with the current market size of $5.6 billion).
MYGN: 32.06 (+0.37), TSRO: 88.20 (-0.50), HSKA: 43.50 (-0.02), INVA: 11.77 (+0.13)
Integra Life Sciences Forges Ahead with Expansion Plans
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 5:06PM CDT
Integra Life Sciences (IART) recently received FDA approval for its Integra Omnigraft Dermal Regeneration Matrix.
IART: 80.50 (-0.95), HSKA: 43.50 (-0.02), FCSC: 1.18 (-0.02), RTRX: 18.47 (-0.18)
Heska (HSKA) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Heska Corporation (HSKA) has been struggling lately, but the selling pressure may be coming to an end soon
HSKA: 43.50 (-0.02)
New Strong Buy Stocks for June 2nd
Swarup Gupta - ZACKS - Thu Jun 02, 8:30AM CDT
New Strong Buy Stocks for June 2nd
HSKA: 43.50 (-0.02), FMBH: 25.34 (+0.34), DISCA: 25.25 (-0.37), LXFR: 11.85 (+0.05), BNS: 48.74 (+0.14)
Galena Biopharma (GALE) in Focus: Stock Moves Up 19.3%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:15AM CDT
Galena Biopharma, Inc. (GALE) shares rose over 19% in the last trading session.
HSKA: 43.50 (-0.02), GALE: 0.46 (unch)
Edge Therapeutics (EDGE) Catches Eye: Stock Soars 19.4%
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:00AM CDT
Edge Therapeutics, Inc (EDGE) was a big mover last session, as the company's shares rose over 19% on the day.
HSKA: 43.50 (-0.02), EDGE: 9.61 (-0.12)
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 80.50 (-0.95), HSKA: 43.50 (-0.02), ANIP: 55.38 (-1.13), NEO: 8.92 (-0.23)
Acorda Shelves Development of Epilepsy Treatment, Plumiaz
Arpita Dutt - Zacks Investment Research - Mon May 23, 6:39AM CDT
Acorda's (ACOR) decision to terminate the development of Plumiaz was based on data from ongoing studies.
HSKA: 43.50 (-0.02), ANIP: 55.38 (-1.13), RTRX: 18.47 (-0.18), ACOR: 25.57 (-0.64)
The Zacks Analyst Blog Highlights: B&G, Dean Foods, Richmont Mines, Chesapeake Utilities and Heska
Zacks Equity Research - Zacks Investment Research - Wed May 18, 8:30AM CDT
The Zacks Analyst Blog Highlights: B&G, Dean Foods, Richmont Mines, Chesapeake Utilities and Heska
CPK: 65.66 (+0.42), HSKA: 43.50 (-0.02), BGS: 47.82 (-0.64), RIC: 10.11 (+0.25), DF: 18.86 (-0.34)
Dodge Market Volatility with These 5 Low-Beta Stocks
Zacks Equity Research - Zacks Investment Research - Tue May 17, 10:29AM CDT
For a long-term investor, it's always safer to invest in low-risk stocks.
CPK: 65.66 (+0.42), HSKA: 43.50 (-0.02), RIC: 10.11 (+0.25), DF: 18.86 (-0.34)
BioDelivery-Collegium Collaborate for Onsolis in U.S.
Zacks Equity Research - Zacks Investment Research - Thu May 12, 4:34PM CDT
BioDelivery Sciences (BDSI) and Collegium Pharmaceutical, have entered into a licensing deal for Onsolis in the U.S.
BDSI: 2.51 (-0.07), HSKA: 43.50 (-0.02), ANIP: 55.38 (-1.13), COLL: 12.63 (-0.11)
Heska to Present at Stifel Dental & Veterinary Conference
PR Newswire - Thu May 12, 3:30PM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
HSKA: 43.50 (-0.02)
Is Heska Corporation (HSKA) a Great Growth Stock?
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:51AM CDT
Heska Corporation (HSKA) looks like an exciting pick for investors as it is poised for strong future growth.
HSKA: 43.50 (-0.02)
Kite Pharma (KITE) Posts Narrower-than-Expected Loss in Q1
Arpita Dutt - Zacks Investment Research - Tue May 10, 8:45AM CDT
Investors will remain focused on Kite's (KITE) progress with its pipeline.
HSKA: 43.50 (-0.02), CBM: 55.01 (+0.85), KITE: 47.68 (-0.85), AMGN: 160.18 (-0.92)
Arena's (ARNA) Q1 Loss Narrower but Revenues Fall Short
Arpita Dutt - Zacks Investment Research - Tue May 10, 7:27AM CDT
Sales of Arena's (ARNA) obesity treatment, Belviq, remain lackluster.
HSKA: 43.50 (-0.02), CBM: 55.01 (+0.85), ANIP: 55.38 (-1.13), ARNA: 1.62 (-0.08)
Juno (JUNO) Posts Wider Loss in Q1, Focus on Pipeline
Arpita Dutt - Zacks Investment Research - Tue May 10, 6:15AM CDT
Even though Juno's (JUNO) Q1 loss was wider-than-expected, investor focus will remain on the company's pipeline progress.
HSKA: 43.50 (-0.02), CBM: 55.01 (+0.85), JUNO: 27.33 (-0.48), CELG: 103.41 (-1.62)
Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast
PR Newswire - Mon May 09, 12:00PM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 43.50 (-0.02)
New Strong Buy Stocks for May 5th
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:13AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
MEP: 8.26 (+0.11), HSKA: 43.50 (-0.02), ANF: 19.13 (+0.04), MCHP: 52.35 (+0.48), LPLA: 23.08 (+0.37)